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Abstract An analysis of wastewater from Krakow (Poland)
for the presence of controlled and uncontrolled stimulant
drugs of abuse was performed. Samples were collected from
the Plaszowwastewater treatment plant, Krakow, Poland, and
preparedby solid phase extraction. TheLC-QTOFMSmethod
was applied for identification and quantification of popular
stimulants: MDMA, mephedrone, 4-MEC, MDPV and
mCPP. Environmental loads of illicit drugs were calculated;
the WWTP discharged loads ranging from 3.6 to 6.7 mg
day-1 1000 inhabitants-1 of MDMA, 3.6 to 7.1 mg
day-1 1000 inhabitants-1 of mephedrone and 4.8 to 5.8 mg
day-1 1000 inhabitants-1 of 4-MEC. The results confirmed the
growing popularity of new psychoactive substances in Poland.
Keywords LC–ESI–QTOF–MS  Wastewater analysis 
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In recent years, a large number of new psychoactive sub-
stances (NPS) have been marketed (Adamowicz et al.
2013; Zuba et al. 2013; Reid et al. 2014; Castiglioni et al.
2015; Report 2015). The first ‘head shops’ offering NPS
were opened in Poland in 2008 and in 2010, around 1500
stores selling NPS without any control were in operation
(Report 2011). Up to May 2009, the most popular class of
substances sold as ‘legal highs’ were piperazines, including
benzylpiperazine (BZP), 1-[3-trifluoromethyl)phenyl]piper-
azine (TFMPP), 1-(4-fluorophenyl)piperazine (pFPP), and
1-(3-chlorophenyl)piperazine (mCPP) (Byrska et al. 2010).
BZP and mCPP seemed to be the most popular and easy
accessible substances for users, therefore the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) carried out a risk assessment on these sub-
stances and noted drug addiction, many intoxications,
including lethal poisonings. Based on their reports, BZP was
banned in almost every European country (including Poland),
whereas mCPP has been actively monitored (Annual Report
2012). After the ban for BZP, the market moved to a new
direction; the first derivatives of cathinone were marketed
(Zuba and Byrska 2013). Mephedrone (4-methylmethcathi-
none, MPD) became the substance of preference by users and
its popularity has been growingmonth bymonth (Zuba 2014).
The popularity of mephedrone was reflected in the increase in
the number of drug addicts. Due to the growing popularity of
NPS, monitoring of drugs of abuse in wastewater had to be
expanded in order to cover a broader range of substances. A
number of papers on quantification of opioids, cannabis
derivatives, codeine,methadone,BZPandmCPP inwastewater
were published (Zuccato et al. 2008; Baker et al. 2012; Thomas
et al. 2012;Andres-Costa et al. 2014;Bijlsmaet al. 2014). Itwas
shown that due to the poor degree of purification in treatment
plants, illicit drugs are still present in effluents being discharged
to surfacewater (Kasprzyk-Hordern et al. 2009; vanNuijs et al.
2009; Zuccato andCastiglioni 2009;Mendoza et al. 2014).Due
to their properties, they can be toxic to aquatic organisms
(Pomati et al. 2007; Rosi-Marshall et al. 2015). Psychoactive
substances have been also identified in drinking water, even
after the treatment process (Castiglioni et al. 2011; Mendoza
et al. 2014). Therefore,monitoring of their presence in different
kinds of water is an important issue.
The aims of this pilot study were to investigate the
profile of stimulant drugs taken by users in Krakow, and to
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estimate the environmental loads and consumption. The
study covered ‘traditional’ drug of abuse, MDMA, and
common novel psychoactive substances, that is mCPP,
mephedrone, 4-MEC and MDPV. This is the first study
based on the prevalence of stimulant drugs in the Krakow
area.
Materials and Methods
Standard solutions of mephedrone and MDPV were pur-
chased from the Australian Government National Mea-
surement Institute (North Ryde, Australia), MDMA from
Cerilliant (Round Rock, TX, USA), mCPP from Lipomed
AG (Arlesheim, Switzerland), while 4-MEC from LGC
Standards Sp. z o.o. (Dziekano´w Les´ny, Poland). The
molecular formulas, physical and chemical properties of
the compounds are summarized in Table 1. The isotope
labelled standard MDMA-D5 (1.0 mg mL-1 in methanol)
was purchased from Cerilliant (Round Rock, TX, USA).
HPLC supergradient grade methanol and ammonia (25 %)
were obtained from POCH (Gliwice, Poland). Hydrochlo-
ric acid (32 %) and formic acid (89–91 %) were purchased
from Merck (Darmstadt, Germany). HPLC-grade acetoni-
trile was purchased from J.T. Baker (Phillipsburg, NJ,
USA). Deionized water was obtained by reverse diffusion
in a Millipore system (Warsaw, Poland).
Effluent samples were collected from the Plaszow
WWTP, Krakow, Poland. It treats approximately
165,000 m3 of urban wastewater per day, which is over
70 % of the total volume of the city’s wastewater. Effluent
water was collected after the secondary treatment, which
involves primary settling, biological treatment and sec-
ondary sedimentation.
Effluent samples were collected in May 2012. Four
wastewater samples (5 L each) were collected once a week,
on Sunday. Equal aliquots of wastewater were taken every
hour over a 24 h period, collected in pre-cleaned poly-
ethylene containers with UV protection and stored at 4C
until the collection process was finished. Then, samples
were transported to the laboratory and processed within
12 h. In the first step, before the solid phase extraction,
wastewater was filtered using MN GF-4 and MN GF-1
glass fibre filters from Macherey–Nagel (Du¨ren, Germany).
Afterwards, samples were acidified to pH 4.5 with 2 M
hydrochloric acid.
Table 1 List of analytes and their properties
Common name
(Acronym)




mCPP 1-(3-Chlorophenyl)piperazine 2.07 Stimulant













a values obtained from ChemSpider Database
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Oasis HLB 3 cc (60 mg/3 mL) extraction cartridges
from Waters (Milford, MA, USA) were used in the ana-
lytical procedure. SPE was performed using a 12-port
vacuum extraction manifold (J.T. Baker, Philipsburg,
USA). The extraction cartridges were conditioned by 2 mL
MeOH/NH4OH (v/v, 95:5) and 2 mL deionised water
adjusted with hydrochloric acid solution to pH 4.5. 500 mL
of samples adjusted to pH 4.5 were spiked with 4 lL
(200 ng) internal standard solution of concentration
50 lg mL-1 before being passed through SPE cartridges.
A flow of 5 mL min-1 water through the cartridge was
achieved by applying a mild vacuum to the extraction
manifold. The respective cartridges were then washed by
10 mL deionised water (pH 4.5) and completely dried
under vacuum. The analytes were eluted twice from the
cartridges with 2 mL of MeOH/NH4OH (v/v, 95:5).
Extracts were pooled to 5 mL vials and stored in a freezer
in temperature -24C for 24/48 h until analysis. Directly
prior to analysis 100 lL (0.025 M) hydrochloric acid were
added to extracts. Subsequently, extracts were evaporated
to 100 lL by nitrogen stream in a Pierce Reacti-Vap III
evaporator and were finally reconstituted with mobile
phase to a volume of 1 mL. The supernatants were suc-
cessively transferred into 2 mL auto sampler vials for
analysis by means of LC–ESI-QTOF-MS. In the experi-
ments, all calibration solutions as well as extracts were
dissolved in starting mobile phase (0.1 % formic acid in
95 % water/5 % acetonitrile).
LC/MS analyses were carried out using an Agilent
Technologies 1200 Series liquid chromatography instru-
ment coupled with a 6520 Accurate-Mass Q-TOF LC/MS
detector equipped with electrospray ionization (ESI) man-
ufactured by the same company. The mobile phase was
composed of a mixture of 0.1 % (v/v) formic acid in water
(A) and in acetonitrile (B). The separation was performed
at 35C using an Ascentic Express C18 column
(7.5 cm 9 2.1 mm 9 2.7 lm) from Supelco. The flow rate
was 0.3 mL min-1, and the volume of injection was 10 lL.
All analyses were carried out in a gradient mode (shown in
relation to content of phase B): 0 min—5 %, 16 min—
20 %, 16.2 min—5 %, 21 min—5 %.
The instrument operated with an electrospray ion source
(ESI) in positive ionization mode. Nitrogen was used as the
drying gas at a temperature of 300C and a flow rate of
10 L min-1 and the nebulizing gas at a pressure of 45 psi.
Capillary voltage was set at 3000 V and skimmer voltage
at 65 V. Fragmentor voltage was set at 120 V. The quad-
rupole was used as an ion guide in MS mode, and for
selection of precursor ions with Dm/z = 1.3 in MS/MS
mode. Nitrogen was used as the collision gas in MS/MS
mode and collision energy was set at 4 V for MDMA and
MDMA D5, 8 V for mephedrone and 4-MEC, 16 V for
mCPP, 24 V for MDPV. Collision energy for compounds
was obtained by using Mass Hunter Optimizer Software,
Version B.02.00 (Agilent Technologies).
Themass rangewas 50–1000 m/z, in bothMS andMS/MS
modes. Spectra were internally mass-corrected in real time
using an automatically introduced reference mass solution
containing two compounds: purine ([M ? H]? = 121.0509)
and HP-921—hexakis(1H,1H,3H-tetrafluoropropoxy)phosp-
hazine ([M ? H]? = 922.0098).
The concentrations of target compounds were deter-
mined by using the main product ion (quantifier) presented
in Table 2. Concentrations in the samples were calculated
by comparing the peak area ratios of the analytes and
surrogate standard to the corresponding ratios in the stan-
dard solutions. The stimulant drugs stock solution with a
concentration of 10 lg mL-1 in methanol was used for
preparation of calibration solutions. Calibrations curves
were obtained from this stock solution spiked in mobile
phase at 5, 10, 25, 50, 100, 250, 500, 1000 ng mL-1. All
calibration solutions contained 200 ng mL-1 of the inter-
nal standard, MDMA D5.
Results and Discussion
Extraction efficiency was tested by placing 500 mL
deionized water adjusted to pH 4.5 in volumetric flasks and
then spiking them with prepared drugs stock solutions.
After manual shaking, the samples were extracted by SPE.
For each sample three extractions were prepared and each




Compounds RT [min] Precursor (m/z) Product 1 (Quantifier) (m/z) Product 2 (Qualifier) (m/z)
MDMA D5 3.614 199.1489 165.0874 136.0494
MDMA 3.88 194.1176 163.0749 105.0709
MPD 4.934 178.1226 160.1116 145.0882
4-MEC 6.571 192.1383 174.1275 146.0961
mCPP 8.095 197.0840 154.0418 119.0731
MDPV 10.639 276.1594 126.1278 135.0442
Product 1 main product ions (quantifier), Product 2 secondary product ions (qualifier)
RT retention time in min, precursor and product mass fragments
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extract was analysed in triplicates. To check for concen-
tration dependencies of the recovery rate and to determine
the limit of quantification from the recovery experiment,
deionized water samples were spiked to 40, 200 and
600 ng L-1 of the target compounds. All the samples were
spiked with labelled internal standard as well as
hydrochloric acid to adjust the pH to 4.5. The eluates were
concentrated and reconstituted with mobile phase to 1 mL
and extracts were analysed by LC–ESI–QTOF–MS. The
results presented in Table 3 show that most recovery rates
were between 50 % and 100 %.
The recovery rates were quantitated and the relative
standard deviations (RSD %) were about 10 %. The
applied conditions of the liquid chromatograph allowed for
the successful separation of all analytes within 11 min.
Before analysis of target compounds, blank measurements
were applied for detection of possible impurities. For all
analytes, molecular ions were selected as precursor ions.
Specific and intense product ions of each target analyte
were used for quantification and a secondary product ion
was used as qualifier ion for confirmatory purposes.
Details of the specific parameters for detection of the
analytes are given in Table 2. Delta retention time in MS/
MS mode was 3 min, the time window wherein the frag-
mentation occurs, i.e. retention time ±1.5 min.
Calibration curves were produced by a weighted (1/x)
linear least square regression. Relative peak areas (ratios of
the analytes to the surrogate standard) were used for cal-
culations. Correlation coefficients, R, were in the range of
0.9982–0.9997. Limits of detection (LOD) and quantifica-
tion (LOQ) were calculated on the basis of signal to noise
ratios (S/N) of 3 and 10, respectively. All parameters are
shown in Table 4.
The analytical results corrected for the average recovery
(shown in Table 3) are shown in Table 5. The highest
concentration found in wastewater samples corresponds to
mephedrone (42.9 ng L-1). The detected concentrations of
MDMA and 4-MEC were similar, ranging between 21.6
and 41.3 ng L-1. As the analytes concentrations in
wastewater samples were low, the results were recalculated
for recoveries at low concentration level (40 ng L-1), but
the differences were insignificant.
MDPV and mCPP were not detected in the tested
wastewater samples.
Table 3 Recoveries (%) of the
spiked samples by Oasis HLB
cartridge
Spiked concentration in H2O mCPP 4-MEC MDPV MPD MDMA
40 ng L-1 61 63 81 39 43
72 63 84 47 43
66 66 79 40 50
200 ng L-1 100 62 110 37 45
93 62 107 39 47
90 59 104 39 47
600 ng L-1 99 59 117 39 46
87 57 106 37 44
104 63 131 40 49
Average recovery rate (%) 86 62 102 39 46
RSD % 17 4 16 7 5
Table 4 Linear ranges,
correlation coefficients (R) of
the calibration curves, sample
based limits of detection (LOD)
and limits of quantification
(LOQ)
Linear range (ng L-1) R LOD (ng L-1) LOQ (ng L-1)
mCPP 5–1000 0.9996 2.2 6.6
4-MEC 5–1000 0.9995 2.7 8.8
MDPV 10–1000 0.9994 5.8 17.5
MPD 5–1000 0.9992 2.0 6.1
MDMA 5–1000 0.9997 2.3 6.9
Table 5 Concentrations in ng L-1 of psychoactive compounds refer
to the weekly sampling intervals in WWTP effluents
Compound Concentrations (ng L-1)
Week 1 Week 2 Week 3 Week 4
mCPP \LOD \LOD \LOD \LOD
4-MEC 35.3 ± 0.7 36.7 ± 2.8 41.3 ± 0.9 29.1 ± 1.4
MDPV \LOD \LOD \LOD \LOD
MPD 42.9 ± 4.6 29.0 ± 4.7 31.9 ± 1.6 21.6 ± 2.4
MDMA 40.7 ± 4.7 40.9 ± 1.2 31.9 ± 1.6 21.6 ± 2.4
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Loads (mg 1000 inhabitants-1 day-1) of illicit drugs
discharged via effluents into the aquatic system were esti-
mated from concentrations of each compound detected in
the effluents (ng L-1) and the daily flow of effluents dis-
charged to the aquatic system. Loads of illicit drugs
(MDMA, mephedrone and 4-MEC), discharged by the
WWTP ranged from 3.6 to 6.7 mg day-1 1000 inhabi-
tants-1 of MDMA, 3.6 to 7.1 mg day-1 1000 inhabi-
tants-1 of mephedrone and 4.8 to 5.8 mg day-1 1000
inhabitants-1 of 4-MEC.
The hazard quotient (HQ) method was used to screen the
toxicological risk level (Mendoza et al. 2014). The lack of
aquatic ecotoxicological data for psychoactive compounds
makes it difficult to conduct proper environmental risk
assessment. For MDMA, Mendoza et al. (Mendoza et al.
2014) published a PNEC of 0.216 lg L-1 based on the
lowest median lethal (effective) concentration (L(E)50) in
algae, cladocerans and fish divided by an assessment factor
of 1000. PNEC derived by the Ecological Structure
Activity Relationships (ECOSAR) modeling. For mephe-
drone and 4-MEC, no PNECs could be found in available
literature. The calculated HQs for MDMA, which are well
below 1, up to 0.188, mean that, as far as data are available,
the environmental risk is low but a potential adverse effect
could be expected for MDMA. The values of HQs esti-
mated in this work for an environmental risk assessment
are in agreement with data reported by Mendoza et al.
(Mendoza et al. 2014) and Bijlsma et al. (Bijlsma et al.
2014). These data were calculated in the effluent of the
WWTP, so this is the worst case scenario because effluents
are diluted further in a surface water.
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